Literature DB >> 3308488

Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity.

V F Quesniaux1, M H Schreier, R M Wenger, P C Hiestand, M W Harding, M H Van Regenmortel.   

Abstract

Although several cytosolic proteins including calmodulin and cyclophilin have been shown to bind cyclosporine, the direct involvement of these proteins in the immunosuppressive activity of cyclosporine remains to be established. In the present study, a quantitative immunoassay for cyclophilin was developed which made it possible to compare its relative affinity for cyclosporine and any of its analogues. The binding of cyclophilin to cyclosporine coated on a solid phase was revealed by anti-cyclophilin rabbit antiserum followed by antiglobulin-enzyme conjugate. This reaction could be inhibited by addition of free cyclosporine or certain cyclosporine analogues. By studying the binding of cyclophilin to more than fifty cyclosporine derivatives modified singly on each of the eleven amino acid residues, it could be shown that cyclophilin binds to the residues of cyclosporine known to be critical for its immunosuppressive activity. These data identify cyclophilin as a highly discriminating stereospecific binding protein for cyclosporine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308488     DOI: 10.1002/eji.1830170921

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

1.  Blocking cyclophilins in the chronic phase of asthma reduces the persistence of leukocytes and disease reactivation.

Authors:  Erik J Stemmy; Molly A Balsley; Rosalyn A Jurjus; Jesse M Damsker; Michael I Bukrinsky; Stephanie L Constant
Journal:  Am J Respir Cell Mol Biol       Date:  2011-04-14       Impact factor: 6.914

Review 2.  A brief review of modern toxicologic pathology in regulatory and explanatory toxicity studies of chemicals.

Authors:  R A Ettlin; M Oberholzer; E Perentes; B Ryffel; M Kolopp; S R Qureshi
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

Review 3.  The cyclosporins.

Authors:  Z Rehácek
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

4.  Identification of housekeeping genes suitable for gene expression analysis in the pearl mussel, Hyriopsis cumingii, during biomineralization.

Authors:  Zhiyi Bai; Jingyun Lin; Keyi Ma; Guiling Wang; Donghong Niu; Jiale Li
Journal:  Mol Genet Genomics       Date:  2014-03-18       Impact factor: 3.291

5.  An immunosuppressive agent, FTY720, increases intracellular concentration of calcium ion and induces apoptosis in HL-60.

Authors:  T Shinomiya; X K Li; H Amemiya; S Suzuki
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

6.  Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence.

Authors:  E R Price; L D Zydowsky; M J Jin; C H Baker; F D McKeon; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

7.  Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages.

Authors:  B Sherry; N Yarlett; A Strupp; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

8.  Comparison of the properties of the CsA analogs monoacetyl CyC (o-acetyl-threonine2 cyclosporin) and methyl-alanyl CsA (N-methyl-L-alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin.

Authors:  S el Rouby; Y Shi; G H Reem
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

9.  Effect of cyclosporin analogues and FK506 on transcellular transport of daunorubicin and vinblastine via P-glycoprotein.

Authors:  K Tanaka; M Hirai; Y Tanigawara; M Yasuhara; R Hori; K Ueda; K Inui
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

10.  Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.

Authors:  Roger G Ptak; Philippe A Gallay; Dirk Jochmans; Andrew P Halestrap; Urs T Ruegg; Luke A Pallansch; Michael D Bobardt; Marie-Pierre de Béthune; Johan Neyts; Erik De Clercq; Jean-Maurice Dumont; Pietro Scalfaro; Kamel Besseghir; Roland M Wenger; Brigitte Rosenwirth
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.